Deal Details

Global Medical REIT Inc. (“GMRE” or the “Company”) (NYSE: GMRE) recently completed a public offering of 2,000,000 shares of the Company’s 8.00% Series B Cumulative Redeemable Preferred Stock, liquidation preference $25.00 per share, at a public offering price of $25.00 per share. The Company received gross proceeds of $50.0 million from the sale of the Series B Cumulative Redeemable Preferred Stock before deducting the underwriting discounts and commissions and estimated offering expenses. The Company also granted the underwriters a 30-day option to purchase up to an additional 300,000 shares of the Series B Preferred Stock to cover over-allotments, if any. GMRE intends to use the net proceeds from the offering for general corporate purposes, which may include funding new acquisitions and repaying indebtedness, including amounts outstanding under the Company’s credit facility.

Baird served as an active bookrunner on this offering.